sparfloxacin has been researched along with Cystitis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumamoto, Y | 1 |
| Hirose, T; Miyake, M; Miyamoto, S; Miyao, N; Sato, T; Takatsuka, K; Tanaka, N; Umehara, T; Yokoo, A; Yoshiaki, K | 1 |
| Hibi, H; Horiba, M; Nagakubo, I; Naide, Y; Okishio, N; Shinoda, M; Suzuki, K; Yanagioka, M | 1 |
2 trial(s) available for sparfloxacin and Cystitis
| Article | Year |
|---|---|
Single-dose treatment of female acute uncomplicated cystitis.
Topics: Acute Disease; Administration, Oral; Anti-Infective Agents; Cefixime; Cefotaxime; Clinical Protocols; Colony Count, Microbial; Cystitis; Fluoroquinolones; Ofloxacin; Quinolones; Recurrence; Treatment Outcome; Urine | 1992 |
[Dose finding study of sparfloxacin in single-dose therapy for female acute uncomplicated cystitis].
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; Cystitis; Double-Blind Method; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Middle Aged; Quinolones | 1992 |
1 other study(ies) available for sparfloxacin and Cystitis
| Article | Year |
|---|---|
[Clinical study of sparfloxacin, a new quinolone derivative, on urinary tract infection].
Topics: Adult; Anti-Infective Agents; Bacteria; Cystitis; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Quinolones; Urinary Tract Infections | 1991 |